Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Din, Omar"'
Autor:
Brown J; Division of Clinical Medicine, University of Sheffield, Sheffield, S10 2SJ, United Kingdom.; Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Rd, Sheffield, S10 2JF, United Kingdom., Paggiosi MA; Division of Clinical Medicine, University of Sheffield, Sheffield, S10 2SJ, United Kingdom., Rathbone E; Huddersfield Royal Infirmary, Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, HD3 3EA, United Kingdom., Gregory W; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, United Kingdom., Bertelli G; Sussex Cancer Centre, University Hospitals Sussex NHS Trust, Bristol Gate, Brighton, BN2 5BD, United Kingdom., Din O; Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Rd, Sheffield, S10 2JF, United Kingdom., McCloskey E; Division of Clinical Medicine, University of Sheffield, Sheffield, S10 2SJ, United Kingdom.; Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Rd, Sheffield, S10 2JF, United Kingdom., Dodwell D; Leeds General Infirmary, LeedsTeaching Hospitals NHS Trust, Leeds, LS1 3EX, United Kingdom., Cameron D; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Crewe Road South, University of Edinburgh, Edinburgh, Edinburgh EH4 2XR, United Kingdom., Eastell R; Division of Clinical Medicine, University of Sheffield, Sheffield, S10 2SJ, United Kingdom.; Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Rd, Sheffield, S10 2JF, United Kingdom., Coleman R; Division of Clinical Medicine, University of Sheffield, Sheffield, S10 2SJ, United Kingdom.; Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Rd, Sheffield, S10 2JF, United Kingdom.
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2024 Mar 04; Vol. 39 (1), pp. 8-16.
Autor:
Brown JE; Department of Oncology and Metabolism, University of Sheffield, Weston Park Hospital, Sheffield. Electronic address: j.e.brown@sheffield.ac.uk., Royle KL; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Gregory W; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Ralph C; Leeds Institute of Medical Research at St James's, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Maraveyas A; Queens Centre for Oncology and Haematology, Faculty of Health Sciences, Hull York Medical School, Hull, UK., Din O; Department of Clinical Oncology, Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Eisen T; Department of Oncology, University of Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Nathan P; Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, UK., Powles T; Barts Cancer Institute, Queen Mary University, London, UK., Griffiths R; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Jones R; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Vasudev N; Leeds Institute of Medical Research at St James's, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Wheater M; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Hamid A; Broomfield Hospital, Mid and South Essex NHS Foundation Trust, Chelmsford, UK., Waddell T; Christie NHS Foundation Trust, Manchester, UK., McMenemin R; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Patel P; Academic Unit of Translational Medical Sciences, University of Nottingham, Nottingham, UK., Larkin J; Royal Marsden NHS Foundation Trust, London, UK., Faust G; Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK., Martin A; Academic Unit of Health Economics, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Swain J; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Bestall J; Leeds Institute of Health Sciences, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., McCabe C; Centre for Public Health, Queens University, Belfast, UK., Meads D; Academic Unit of Health Economics, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Goh V; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Min Wah T; Department of Radiology, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Brown J; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Hewison J; Leeds Institute of Health Sciences, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Selby P; Leeds Institute of Medical Research at St James's, Leeds Institute for Medical Research, University of Leeds, Leeds, UK., Collinson F; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Mar; Vol. 24 (3), pp. 213-227. Date of Electronic Publication: 2023 Feb 13.
Autor:
Parker CC; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom., James ND; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom., Brawley CD; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Clarke NW; The Christie Hospital, Manchester, United Kingdom.; Salford Royal Hospitals, Manchester, United Kingdom., Ali A; The Christie Hospital, Manchester, United Kingdom., Amos CL; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Attard G; UCL Cancer Institute, UCL, London, United Kingdom., Chowdhury S; Guys and St Thomas's NHS Foundation Trust, London, United Kingdom., Cook A; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Cross W; St James's University Hospital, Leeds, United Kingdom., Dearnaley DP; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom., Douis H; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Gilbert DC; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Gilson C; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Gillessen S; Istituto Oncologico della Svizzera Italiana, EOC, Bellinzona, Switzerland.; Università della Svizzera Italiana, Lugano, Switzerland., Hoyle A; The Christie Hospital, Manchester, United Kingdom.; Salford Royal Hospitals, Manchester, United Kingdom., Jones RJ; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Langley RE; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Malik ZI; Clatterbridge Cancer Centre, Liverpool, United Kingdom., Mason MD; Cardiff University, Cardiff, United Kingdom., Matheson D; University of Wolverhampton, Wolverhampton, United Kingdom., Millman R; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Rauchenberger M; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Rush H; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom.; Guys and St Thomas's NHS Foundation Trust, London, United Kingdom., Russell JM; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Sweeney H; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Bahl A; University Hospitals Bristol NHS Trust, Bristol, United Kingdom., Birtle A; Rosemere Cancer Centre, Lancs Teaching Hospitals, University of Manchester, Manchester, United Kingdom.; UCLan, Lanchashire, United Kingdom., Capaldi L; Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom., Din O; Weston Park Cancer Centre, Sheffield, United Kingdom., Ford D; University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Gale J; Queen Alexandra Hospital, Portsmouth, United Kingdom., Henry A; University of Leeds, Leeds, United Kingdom., Hoskin P; The Christie Hospital, Manchester, United Kingdom.; Mount Vernon Cancer Centre, Northwood, United Kingdom., Kagzi M; The James Cook University Hospital, Middlesbrough, United Kingdom., Lydon A; Torbay and South Devon NHS Trust, Torbay, United Kingdom., O'Sullivan JM; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, United Kingdom., Paisey SA; Hampshire Hospitals NHS Foundation Trust, Hampshire, United Kingdom., Parikh O; Royal Preston Hospital, Preston, United Kingdom., Pudney D; South West Wales Cancer Centre, Swansea, United Kingdom., Ramani V; The Christie Hospital, Manchester, United Kingdom.; Manchester University Hospitals NHS Trust, Manchester, United Kingdom., Robson P; Clatterbridge Cancer Centre, Liverpool, United Kingdom., Srihari NN; Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, United Kingdom., Tanguay J; Velindre Cancer Centre, Cardiff, United Kingdom., Parmar MKB; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom., Sydes MR; MRC Clinical Trials Unit at UCL, UCL, London, United Kingdom.
Publikováno v:
PLoS medicine [PLoS Med] 2022 Jun 07; Vol. 19 (6), pp. e1003998. Date of Electronic Publication: 2022 Jun 07 (Print Publication: 2022).
Autor:
Dearnaley D; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Hinder V; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Hijab A; Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Horan G; Clinical Oncology, The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK., Srihari N; Clinical Oncology, The Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK., Rich P; Radiology, St George's University Hospitals NHS Foundation Trust, London, UK., Houston JG; Imaging Science and Technology, University of Dundee, Dundee, UK., Henry AM; Clinical Oncology, University of Leeds, Leeds, UK., Gibbs S; Clinical Oncology, Barking, Havering and Redbridge University Hospitals NHS Trust, London, UK., Venkitaraman R; Clinical Oncology, East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK., Cruickshank C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Hassan S; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Miners A; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK., Mason M; Clinical Oncology, Cardiff University, Cardiff, UK., Pedley I; Clinical Oncology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Payne H; Clinical Oncology, University College London Hospitals NHS Foundation Trust, London, UK., Brock S; Clinical Oncology, University Hospitals Dorset NHS Foundation Trust, Poole, UK., Wade R; Clinical Oncology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Robinson A; Clinical Oncology, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK., Din O; Clinical Oncology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Lees K; Clinical Oncology, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK., Graham J; Clinical Oncology, Somerset NHS Foundation Trust, Taunton, UK., Worlding J; Oncology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Murray J; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Parker C; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Griffin C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Sohaib A; Urology Unit, Royal Marsden NHS Foundation Trust, London, UK., Hall E; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK. Electronic address: emma.hall@icr.ac.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Apr; Vol. 23 (4), pp. 501-513. Date of Electronic Publication: 2022 Mar 10.
Autor:
Pang KH; Academic Urology Unit, University of Sheffield, Sheffield, UK; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Thomas F; Department of Urology, Doncaster Royal Infirmary, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, UK., Novara G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy., Din OS; Cancer Research Centre, Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Morgan SL; Department of Histopathology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Hussain SA; Cancer Research Centre, Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Jubber I; Academic Urology Unit, University of Sheffield, Sheffield, UK; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Noon AP; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Catto JWF; Academic Urology Unit, University of Sheffield, Sheffield, UK; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Rosario DJ; Academic Urology Unit, University of Sheffield, Sheffield, UK; Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Electronic address: d.j.rosario@sheffield.ac.uk.
Publikováno v:
European urology focus [Eur Urol Focus] 2021 May; Vol. 7 (3), pp. 554-565. Date of Electronic Publication: 2020 Jun 21.
Autor:
Radwan TF; AT Medics Ltd, London, London, UK., Agyako Y; AT Medics Ltd, London, London, UK., Ettefaghian A; AT Medics Ltd, London, London, UK., Kamran T; AT Medics Ltd, London, London, UK., Din O; AT Medics Ltd, London, London, UK., Tahir MA; AT Medics Ltd, London, London, UK., Schofield P; School of Population Health and Environmental Sciences, King's College London, London, UK., L'Esperance V; AT Medics Ltd, London, London, UK veline.lesperance@kcl.ac.uk.; School of Population Health and Environmental Sciences, King's College London, London, UK.
Publikováno v:
BMJ open quality [BMJ Open Qual] 2021 Feb; Vol. 10 (1).
Autor:
Parker CC; Academic Urology Unit, Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. Electronic address: chris.parker@icr.ac.uk., James ND; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Brawley CD; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK., Clarke NW; Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK; Department of Urology, Salford Royal Hospitals, Manchester, UK., Hoyle AP; Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK; Department of Urology, Salford Royal Hospitals, Manchester, UK., Ali A; Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK; The FASTMAN/Genito-Urinary Cancer Research Groups, Division of Cancer Sciences, and Belfast-Manchester Movember Centre of Excellence, Manchester Cancer Research Centre, University of Manchester, Manchester, UK., Ritchie AWS; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK., Attard G; UCL Cancer Institute, UCL, London, UK., Chowdhury S; Department of Medical Oncology, Guy's & St Thomas' NHS Foundation Trust, London, UK., Cross W; Department of Urology, St James University Hospital, Leeds, UK., Dearnaley DP; Academic Urology Unit, Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK., Gillessen S; Division of Cancer Sciences, University of Manchester and the Christie, Manchester, UK; Division of Oncology and Haematology, Kantonsspital, St Gallen, Switzerland., Gilson C; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK., Jones RJ; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK., Langley RE; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK., Malik ZI; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Mason MD; Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK., Matheson D; Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK., Millman R; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK., Russell JM; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Thalmann GN; Department of Urology, University Hospital, Inselspital, Bern, Switzerland., Amos CL; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK., Alonzi R; Mount Vernon Cancer Centre, London, UK., Bahl A; Bristol Haematology and Oncology Centre, Bristol, UK., Birtle A; Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston, UK; School of Cancer Sciences, University of Manchester, Manchester, UK., Din O; Department of Clinical Oncology, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Douis H; Department of Radiology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK., Eswar C; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Gale J; Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth, UK., Gannon MR; Department of Health Services Research, London School of Hygiene & Tropical Medicine, London, UK., Jonnada S; Department of Oncology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK., Khaksar S; St Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, UK., Lester JF; Velindre Cancer Centre, Cardiff, UK., O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK., Parikh OA; Department of Clinical Oncology, East Lancashire Hospitals NHS Trust, Blackburn, UK., Pedley ID; Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK., Pudney DM; Clinical Oncology, Singleton Hospital, Swansea, UK., Sheehan DJ; Exeter Oncology Centre, Royal Devon & Exeter Hospital, Exeter, UK., Srihari NN; Department of Oncology, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK., Tran ATH; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Parmar MKB; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK., Sydes MR; Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK. Electronic address: mrcctu.stampede-publications@ucl.ac.uk.
Publikováno v:
Lancet (London, England) [Lancet] 2018 Dec 01; Vol. 392 (10162), pp. 2353-2366. Date of Electronic Publication: 2018 Oct 21.
Autor:
Powles T; Barts Cancer Institute, Experimental Cancer Medicine Centre, Barts Health, Queen Mary University of London, London, UK; The Royal Free NHS Foundation Trust, London, UK. Electronic address: thomas.powles@bartshealth.nhs.uk., Wheater M; Southampton NHS Foundation Trust, Southampton, UK., Din O; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Geldart T; Royal Bournemouth Hospital, Bournemouth, UK., Boleti E; The Royal Free NHS Foundation Trust, London, UK., Stockdale A; Arden Cancer Centre, University Hospital, Coventry, UK., Sundar S; Nottingham University Hospitals NHS trust, Nottingham, UK., Robinson A; Sussex Cancer Centre, Brighton, UK., Ahmed I; Southend NHS Trust, Southend, UK., Wimalasingham A; Barts Cancer Institute, Experimental Cancer Medicine Centre, Barts Health, Queen Mary University of London, London, UK., Burke W; AstraZeneca UK Limited, Quantitative Clinical Pharmacology, Macclesfield, UK., Sarker SJ; Barts Cancer Institute, Experimental Cancer Medicine Centre, Barts Health, Queen Mary University of London, London, UK., Hussain S; University of Liverpool, Clatterbridge Cancer Centre, Liverpool, UK., Ralph C; St. James's University Hospital, University of Leeds, Leeds, UK.
Publikováno v:
European urology [Eur Urol] 2016 Mar; Vol. 69 (3), pp. 450-6. Date of Electronic Publication: 2015 Sep 11.
Autor:
Din OS; Dept. of Clinical Oncology, Weston Park Hospital, Sheffield, UK., Harden SV, Hudson E, Mohammed N, Pemberton LS, Lester JF, Biswas D, Magee L, Tufail A, Carruthers R, Sheikh G, Gilligan D, Hatton MQ
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2013 Oct; Vol. 109 (1), pp. 8-12. Date of Electronic Publication: 2013 Oct 03.
Autor:
Murray LJ; Department of Clinical Oncology, Weston Park Hospital, Sheffield, United Kingdom. Electronic address: lmurray@doctors.org.uk., Din OS; Department of Clinical Oncology, Weston Park Hospital, Sheffield, United Kingdom., Kumar VS; Department of Clinical Oncology, Royal Preston Hospital, Preston, United Kingdom., Dixon LM; Department of Clinical Oncology, Weston Park Hospital, Sheffield, United Kingdom., Wadsley JC; Department of Clinical Oncology, Weston Park Hospital, Sheffield, United Kingdom.
Publikováno v:
Practical radiation oncology [Pract Radiat Oncol] 2012 Oct-Dec; Vol. 2 (4), pp. 257-264. Date of Electronic Publication: 2012 Feb 10.